The Center for Integration of Science and Industry is proud to present the Innovator’s Business Series.
The Innovator's Business Series features talks and informal discussions with thought leaders from academia and industry focused on best practices in translational science. Speakers present the perspective of successful innovators in translating scientific advances into public value. The theme of the series centers on the need for integrating technological and business innovation in the fields of biotechnology, healthcare, high-tech and alternative energy.
Delivering on the Promise of Gene Therapy
Tuesday, February 6, 2018
After 25 years of anticipation, the first gene therapy product was approved in 2017. This is an amazing time in gene therapy and uniQure is a leader in the field. uniQure’s Chief Executive Officer, Matt Kapusta, will talk about creating transformative therapies for patients with rare diseases and the process of bringing innovative cures to market.
Fred Ledley discusses Bentley’s biotechnology mini-MBA and what it offers you and your company. WATCH VIDEO
Recent Innovator's Business Series Speakers
Professor, Practice of International Development
Director, Science, Technology, and Globalization Project
Faculty Chair of the Mason Fellows Program
Belfer Center for Science and International Affairs
Harvard Kennedy School
Distinguished Professor of Political Science, Northeastern University
Governor of Massachusetts (1975-1979, 1983-1991)
1988 Democratic Nominee for President of the United States
Former General Council BASF Bioresearch
Former President BASF Bioresearch
President & CEO, MassBio
President and Chief Executive Officer of Boston Children's Hospital
President Emeritus and Senior Fellow of the Institute for Healthcare Improvement
Formerly the Administrator of the Centers for Medicare & Medicaid Services
Executive Chairman, Alkeus Pharmaceuticals, Inc.
Formerly the President, CEO and Chairman of Vertex Pharmaceuticals
Executive Vice-President for Technology and Innovation, IBM (retired)
President and CEO of Envivo Pharmaceuticals
Formerly the President and CEO of Massachusetts Life Sciences Center